NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES
TORONTO, Ontario and CAMBRIDGE, Mass. - October 23, 2020 - ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company
Related News
SEC Filing (8-K) - Current Report Filing
ex_207759.htm Exhibit 10.1 18,269,230 Shares of Common Stock Warrants to Purchase 9,134,615 Shares of Common Stock Isoray, Inc. UNDERWRITING AGREEMENT October 20, 2020...
Public Technologies 2020-10-22SEC Filing (424B5) - Supplemental Prospectus
tm2033321-1_424b5 - none - 7.7473678s TABLE OF CONTENTS The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be...
Public Technologies 2020-10-22SEC Filing (S-1/A) - Registration Statement - General Form (Amendment)
Exhibit 1.1 Bull Horn Holdings Corp. 7,500,000 Units Underwriting Agreement October [●], 2020 Imperial Capital, LLC 10100 Santa Monica Boulevard, Suite 2400 Los Angeles,...
Public Technologies 2020-10-22SEC Filing (6-K) - Current Report by Foreign Issuer
mogo_ex991.htm EXHIBIT 99.1 MOGO INC. as the Corporation and COMPUTERSHARE TRUST COMPANY OF CANADA as the Warrant Agent...
Public Technologies 2020-10-22SEC Filing (F-3/A) - Registration Statement by Foreign Private Issuer - Specific Transactions (Amendment)
F-3/A Table of Contents As filed with the United States Securities and Exchange Commission on October 22, 2020 Registration No. 333-249463 UNITED STATES SECURITIES AND...
Public Technologies 2020-10-22NeuPath Health Inc. Announces Increase to Bought Deal Financing to $10.4 Million
TORONTO, /CNW/ - NeuPath Health Inc. (TSX-V:NPTH) ("NeuPath" or the "Company"), Canada's largest provider of chronic pain management services, is pleased to announce that...
Canada Newswire 2020-10-20SEC Filing (POS AM) - Post-Effective Amendment to Registration Statement
As filed with the Securities and Exchange Commission on October 19, 2020 Registration No. 333-215915 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
Public Technologies 2020-10-20